Action 600664 HARBIN PHARMACEUTICAL GROUP CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Harbin Pharmaceutical Group Co., Ltd.

Actions

600664

CNE0000009T3

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
3,01 CNY +6,36 % Graphique intraday de Harbin Pharmaceutical Group Co., Ltd. +7,89 % -10,15 %
25/04 Harbin Pharmaceutical Group Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
11/04 Harbin Pharma va moderniser la base de production de sa filiale pour 50 millions de yuans MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Roxatidine Hydrochloride for Injection of Harbin Pharma's Subsidiary Passes Drug Regulator's Evaluation
Harbin Pharmaceutical Group's Cefotiam Hydrochloride Selected for China's Centralized Procurement Bid
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Harbin Pharmaceutical Group Co., Ltd.(XSSC:600664) added to S&P Global BMI Index
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Jian´anxi Food Technology Co., Ltd announced that it expects to receive $20 million in funding from Harbin Pharmaceutical Group Co., Ltd.
Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement Product
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600664
  4. Actualités Harbin Pharmaceutical Group Co., Ltd.
  5. Autres langues